The AGV M4 effectively reduced IOP in the first postoperative month, but IOP steadily increased thereafter. Consequently, failure rates were high after 1 year of follow-up.

No abstract

The outstanding questions about the role of multimodal treatment in ACC of the lacrimal gland can only be set to rest by a robust prospective randomized multicentric study, which may remain only a utopian dream given the rarity of the tumor. Until then, smaller studies like ours which show a trend towards improved outcomes may help stimulate the evolution of logical and oncologically sound treatment protocols. The title of our study "Does Multimodal Treatment Improve Eye and Life Salvage in Adenoid Cystic Carcinoma of the Lacrimal Gland?" poses a provocative question, and it does provide the best-possible answer under the circumstances."The question is the answer. " -Thomas Vato